Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T53952 | Target Info | |||
Target Name | Homeodomain interacting protein kinase 2 (HIPK2) | ||||
Synonyms | hHIPk2; Homeodomain-interacting protein kinase 2 | ||||
Target Type | Literature-reported Target | ||||
Gene Name | HIPK2 | ||||
Biochemical Class | Kinase | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Acyltransferases | [+] 1 Acyltransferases | + | |||
Interacting Protein Name | E3 ubiquitin-protein ligase SIAH1 (SIAH1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SIAH1A | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [1] | |||
2 | Affinity Capture-Western | [2] | |||
3 | Affinity Capture-Western | [3] | |||
4 | Reconstituted Complex | [1] | |||
5 | Yeast two hybrid | [1] | |||
6 | Yeast two hybrid | [3] | |||
Beta-transducin repeats | [+] 1 Beta-transducin repeats | + | |||
Interacting Protein Name | DDB1- and CUL4-associated factor 7 (DCAF7) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | AN11; HAN11; SWAN.1; WDR68 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [4] | |||
2 | Affinity Capture-Western | [5] | |||
3 | Co-localization | [4] | |||
4 | Reconstituted Complex | [4] | |||
5 | Yeast two hybrid | [4] | |||
Pore-forming toxins | [+] 1 Pore-forming toxins | + | |||
Interacting Target Name | Cellular tumor antigen p53 (TP53) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tumor suppressor p53; Phosphoprotein p53; P53; Antigen NY-CO-13 | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [6] | |||
2 | Affinity Capture-Western | [7] | |||
3 | Affinity Capture-Western | [8] | |||
4 | Biochemical Activity | [6] | |||
5 | Biochemical Activity | [7] | |||
6 | Reconstituted Complex | [9] | |||
Transcription regulators | [+] 1 Transcription regulators | + | |||
Interacting Protein Name | Transcriptional activator Myb (MYB) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Transcriptional activator Myb; Proto-oncogene c-Myb | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [10] | |||
2 | Reconstituted Complex | [11] | |||
Ubiquitin related proteins | [+] 1 Ubiquitin related proteins | + | |||
Interacting Target Name | Ubiquitin-protein ligase E3 Mdm2 (MDM2) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RING-type E3 ubiquitin transferase Mdm2; P53-binding protein Mdm2; Oncoprotein Mdm2; MDM2 protein; Hdm2; E3 ubiquitin-protein ligase Mdm2; Double minute 2 protein | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [12] | |||
2 | Biochemical Activity | [7] | |||
Other proteins | [+] 1 Other proteins | + | |||
Interacting Protein Name | Promyelocytic leukemia protein (PML) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | MYL; PP8675; RNF71; TRIM19 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [13] | |||
2 | Affinity Capture-Western | [14] | |||
3 | Biochemical Activity | [15] | |||
4 | Biochemical Activity | [14] | |||
5 | Co-localization | [16] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | An inducible autoregulatory loop between HIPK2 and Siah2 at the apex of the hypoxic response. Nat Cell Biol. 2009 Jan;11(1):85-91. | ||||
REF 2 | Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR. Nat Cell Biol. 2008 Jul;10(7):812-24. | ||||
REF 3 | Stabilization of HIPK2 by escape from proteasomal degradation mediated by the E3 ubiquitin ligase Siah1. Cancer Lett. 2009 Jul 8;279(2):177-84. | ||||
REF 4 | The WD40-repeat protein Han11 functions as a scaffold protein to control HIPK2 and MEKK1 kinase functions. EMBO J. 2010 Nov 17;29(22):3750-61. | ||||
REF 5 | The adaptor protein DCAF7 mediates the interaction of the adenovirus E1A oncoprotein with the protein kinases DYRK1A and HIPK2. Sci Rep. 2016 Jun 16;6:28241. | ||||
REF 6 | Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nat Cell Biol. 2002 Jan;4(1):1-10. | ||||
REF 7 | MDM2-regulated degradation of HIPK2 prevents p53Ser46 phosphorylation and DNA damage-induced apoptosis. Mol Cell. 2007 Mar 9;25(5):739-50. | ||||
REF 8 | XAF1 directs apoptotic switch of p53 signaling through activation of HIPK2 and ZNF313. Proc Natl Acad Sci U S A. 2014 Oct 28;111(43):15532-7. | ||||
REF 9 | Differential interactions of the homeodomain-interacting protein kinase 2 (HIPK2) by phosphorylation-dependent sumoylation. FEBS Lett. 2005 Jun 6;579(14):3001-8. | ||||
REF 10 | Wnt-1 signal induces phosphorylation and degradation of c-Myb protein via TAK1, HIPK2, and NLK. Genes Dev. 2004 Apr 1;18(7):816-29. | ||||
REF 11 | The Wnt-NLK signaling pathway inhibits A-Myb activity by inhibiting the association with coactivator CBP and methylating histone H3. Mol Biol Cell. 2005 Oct;16(10):4705-13. | ||||
REF 12 | HIPK2 inhibits both MDM2 gene and protein by, respectively, p53-dependent and independent regulations. FEBS Lett. 2005 Oct 24;579(25):5473-80. | ||||
REF 13 | Control of nuclear HIPK2 localization and function by a SUMO interaction motif. Biochim Biophys Acta. 2011 Feb;1813(2):283-97. | ||||
REF 14 | PML tumor suppressor is regulated by HIPK2-mediated phosphorylation in response to DNA damage. Oncogene. 2009 Feb 5;28(5):698-708. | ||||
REF 15 | SUMOylation-dependent localization of IKKepsilon in PML nuclear bodies is essential for protection against DNA-damage-triggered cell death. Mol Cell. 2010 Feb 26;37(4):503-15. | ||||
REF 16 | Role of the SUMO-interacting motif in HIPK2 targeting to the PML nuclear bodies and regulation of p53. Exp Cell Res. 2011 Apr 15;317(7):1060-70. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.